Repeated application of DNCB induces AD-like skin lesions in mice, which indicate clinical features of human AD such as increased level of serum IgE levels and Th2 cytokines as well as a defected skin barrier [19,20]. This evidence concerns the gene IGHE and Alzheimer disease.